4/A//SEC Filing
Bell John K 4/A
Accession 0000905718-19-000779
CIK 0001498382other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:45 PM ET
Size
6.3 KB
Accession
0000905718-19-000779
Insider Transaction Report
Form 4/AAmended
Bell John K
Director
Transactions
- Purchase
Common Stock
2019-09-13$0.68/sh+35,000$23,744→ 35,000 total(indirect: Held by Registered Retirement Income Fund)
Holdings
- 9,701(indirect: Held by Onbelay Capital Inc.)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6551 to $0.68 per share, inclusive. The reporting person undertakes to provide to DelMar Pharmaceuticals, Inc., any security holder of DelMar Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]This Form 4/A amends the Form 4 filed by the reporting person on September 16, 2019 solely to amend the disclosure of the shares beneficially owned as of such date by the reporting person.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001569585
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:45 PM ET
- Size
- 6.3 KB